GLP-1 injection angle debate: Does 45° vs. 90° actually matter?

What did @simplymyglp1journ actually say?

The creator walked back a previous post after receiving corrections from followers, which is worth crediting upfront. Her core argument: 90-degree injections risk hitting muscle, while 45 degrees is "the safest way" to hit subcutaneous tissue. She also emphasized pinching the skin, choosing fatty injection sites, and factoring in needle size and body composition. She was careful to disclaim medical authority throughout.

This is a reasonable summary of general subcutaneous injection principles. She's not selling anything, not prescribing doses, and she's directing viewers back to their providers. That matters in a space full of people doing the opposite. The information isn't perfect, but the intent is clearly harm reduction.

Does the science back this up?

Mostly, yes, with some important nuance. The 45-versus-90-degree debate is real in clinical literature, but the answer is more conditional than "45 is safest." It depends heavily on needle length, not just body composition.

A 2016 review by Gibney et al. in Diabetes, Obesity and Metabolism found that needle length is the primary determinant of whether insulin injections reach muscle rather than subcutaneous tissue. For short needles (4-6mm), 90-degree injection in most adults carries low intramuscular risk. For longer needles (8mm or more), 45-degree angle and skin pinching meaningfully reduce intramuscular injection risk, particularly in leaner individuals. The creator touched on this when she mentioned needle size as a factor, which shows she's done some homework.

Skin pinching, which she correctly emphasized, is validated in the same literature. A 2015 study by Hirsch et al. in Current Medical Research and Opinion confirmed that pinching significantly increases subcutaneous tissue depth at common injection sites, reducing intramuscular risk across body types.

What did they get wrong (or right)?

She got more right than wrong, but there's one claim worth pushing back on. Saying "the safest way to do a subcutaneous injection is to do the 45-degree angle" is an overgeneralization. For someone using a short 4mm pen needle, 90 degrees is perfectly safe and is actually the recommendation in clinical guidance for those needle lengths.

The framing that 90 degrees is inherently riskier than 45 degrees could lead someone using a short needle to unnecessarily complicate their injection technique, which introduces its own errors. Angle recommendation should always follow from needle length first, body composition second.

What she got right: the pinching guidance is solid. The point about choosing sites with more subcutaneous fat is clinically sound. Her acknowledgment that body composition changes the calculus is accurate. And her provider-first framing at the end is exactly what a responsible creator should say.

What should you actually know?

If you're injecting any subcutaneous peptide or medication, here's what the evidence actually supports. Needle length is your first decision point. For 4-5mm needles, 90 degrees with or without a pinch is generally appropriate for most adults. For 6-8mm needles, a pinch and 45-degree angle lowers intramuscular risk, especially for leaner individuals.

Injection site rotation matters, and this video didn't mention it. Injecting the same spot repeatedly causes lipohypertrophy, which is a buildup of fatty tissue that affects absorption. A 2014 paper by Frid et al. in Diabetes & Metabolism identified poor site rotation as one of the most common causes of erratic drug absorption in patients self-injecting.

If you're using compounded peptides specifically, the needle length and concentration in your vial matter for technique decisions. These are not identical to branded formulations, and your injection protocol should come from whoever prescribed or supervised your therapy, not from a social media thread, including this one.